The UBC's Okanagan Campus is University of British Columbia's campus located in Kelowna, British Columbia, Canada. The 209-hectare campus is the research and innovation hub in the southern interior of the province, in British Columbia's Okanagan Valley, and home to over 11,562 undergraduate and graduate students.

During the past decade, University of British Columbia Okanagan conducted 56 clinical trials. In the 10-year time frame, 56 clinical trials started and 1 clinical trials were completed, i.e. on average, 1.8% percent of trials that started reached the finish line to date. In the past 5 years, 31 clinical trials started and 1 clinical trials were completed. i.e. 3.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of British Columbia Okanagan" #1 sponsor was "University of British Columbia" with 51 trials, followed by "Sherry Stewart" with 1 trials sponsored, "St. Justine's Hospital" with 1 trials sponsored, "Tilray" with 1 trials sponsored and "University of Alberta" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of British Columbia Okanagan" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 4 trials as a collaborator, "Mitacs" with 4 trials as a collaborator, "University of British Columbia" with 4 trials as a collaborator, "Dalhousie University" with 2 trials as a collaborator and "Interior Health" with 2 trials as a collaborator. Other collaborators include 42 different institutions and companies that were collaborators in the rest 48 trials.

According to Clinical.Site data, the most researched conditions in "University of British Columbia Okanagan" are "Diet Modification" (5 trials), "Spinal Cord Injuries" (4 trials), "Type 2 Diabetes" (4 trials), "Chronic Obstructive Pulmonary Disease" (3 trials) and "Ketosis" (3 trials). Many other conditions were trialed in "University of British Columbia Okanagan" in a lesser frequency.

Most popular intervention types in "University of British Columbia Okanagan" are "Behavioral" (23 trials), "Other" (19 trials), "Dietary Supplement" (13 trials), "Drug" (7 trials) and "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Ketone monoester" (3 trials), "Acetazolamide" (2 trials), "Methazolamide" (2 trials) and "(R)-3-hydroxybutyl (R)-3-hydroxybutyrate ketone monoester" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of British Columbia Okanagan" are 52 trials for "All" genders, 3 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "University of British Columbia Okanagan". 3 are not yet recruiting, 11 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 35 completed trials in University of British Columbia Okanagan, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University of British Columbia Okanagan, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 48 trials that are defined as “Not Applicable".